Healthcare Services

Needle-Free Drug Delivery Devices Market Revenue Expected to Reach $29.91 Billion by 2030 with 9.7% CAGR

April 2, 2026April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Needle-Free Drug Delivery Devices Market Projected To Become By 2030 Based On Its 2026 Valuation?

The needle-free drug delivery devices market size has seen substantial growth over recent years. It is anticipated to expand from $18.54 billion in 2025 to $20.65 billion in 2026, registering a compound annual growth rate (CAGR) of 11.4%. This historic expansion can be ascribed to several factors, including needle phobia experienced by patients, the quest for safer injection alternatives, an uptick in infectious disease vaccinations, the inherent limitations of traditional needle-based techniques, and early innovations in jet injection mechanisms.

The market size for needle-free drug delivery devices is set to experience significant expansion over the next few years. It is projected to climb to $29.91 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.7%. This growth during the forecast period is driven by the increasing prevalence of chronic diseases, a growing embrace of self-administration therapies, the expansion of telemedicine and remote care services, rising demand for minimally invasive drug delivery methods, and advancements in microneedle and transdermal technologies. Prominent trends expected in this period include an increasing demand for painless drug delivery techniques, wider adoption of home-based drug delivery solutions, a rise in the use of needle-free devices for pediatric applications, continued growth in self-administration treatments for chronic conditions, and the broader expansion of needle-free vaccine delivery systems.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Needle-Free Drug Delivery Devices Market?

The expanding occurrence of diabetes is projected to fuel the expansion of the needle-free drug delivery device market moving ahead. Diabetes is a chronic medical condition characterized by elevated blood sugar, resulting from insufficient insulin generation or the body’s inefficient use of insulin. The surge in diabetes cases is attributable to inactive lifestyles, poor eating habits, genetic factors, increasing urbanization, and an aging demographic, further exacerbated by restricted healthcare access and growing global obesity. In diabetes management, needle-free drug delivery devices offer an alternative method for administering insulin, replacing traditional injections. These devices utilize technologies like jet injectors or transdermal patches to deliver insulin subcutaneously without needles, thereby reducing the typical discomfort and apprehension associated with injections and improving patient comfort. As an illustration, in June 2024, the National Health Service, a UK government department, reported that in 2023, the NHS identified more than 549,000 new individuals in England facing a risk of type 2 diabetes. This raised the overall count of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This figure signifies a considerable increase from 3,065,825 in 2022, marking an increment of nearly 20%. Consequently, the rising incidence of diabetes is fueling the expansion of the needle-free drug delivery device market.

What Segment Groups Are Identified Within The Needle-Free Drug Delivery Devices Market?

The needle-free drug delivery devices market covered in this report is segmented –

1) By Device Type: Inhalers, Jet Injectors, Novel Needles, Transdermal Patches

2) By Application: Pain Management, Vaccine Delivery, Pediatric Injections, Insulin Delivery, Other Applications

3) By End-User: Hospitals And Clinics, Home Healthcare

Subsegments:

1) By Inhalers: Dry Powder Inhalers (DPI), Metered Dose Inhalers (MDI), Nebulizers

2) By Jet Injectors: High-Pressure Jet Injectors, Spring-Powered Jet Injectors, Battery-Operated Jet Injectors

3) By Novel Needles: Micro-Needle Arrays, Nano-Needle Arrays

4) By Transdermal Patches: Microneedle Patches, Conventional Patches

How Are Trends Shaping The Direction Of The Needle-Free Drug Delivery Devices Market?

Major companies in the needle-free drug delivery device market are prioritizing advanced solutions, such as dual-chamber inhalers, to enhance efficacy and ease of administration, thereby addressing the evolving requirements of patients and healthcare providers. A dual-chamber inhaler is a system featuring two compartments capable of holding different medications independently. This design facilitates the combination of multiple drugs into a single inhaler, simplifying treatment and increasing patient convenience. For instance, in April 2024, Berry Global, a US-based plastic manufacturing company, launched the BerryHaler, an innovative dry powder inhaler (DPI) aimed at revolutionizing patient-centered healthcare solutions. This dual-chamber inhaler includes a dose counter, ensuring precise medication delivery. Its complete plastic construction, free of any metal parts, makes it suitable for complex inhalation treatments, streamlining dosage and effectively combining multiple drugs. Its advanced functionalities comprise a bi-directional mouthpiece cover for convenience and hygiene, alongside audible signals to confirm proper usage. The integrated dose counter helps in accurately monitoring medication usage, thus preventing dosage errors.

Which Companies Hold Significant Positions In The Needle-Free Drug Delivery Devices Market?

Major companies operating in the needle-free drug delivery devices market are 3M Company, Medtronic plc, Novo Nordisk AS, Becton Dickinson and Company, Insulet Corporation, MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG, Bayer AG, Antares Pharma Inc., Inovio Pharmaceuticals Inc.

Read the full needle-free drug delivery devices market report here:

https://www.thebusinessresearchcompany.com/report/needle-free-drug-delivery-devices-global-market-report

Which Regions Are Projected To Dominate The Needle-Free Drug Delivery Devices Market In The Coming Years?

North America was the largest region in the needle-free drug delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Needle-Free Drug Delivery Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15615&type=smp

Browse Through More Reports Similar to the Global Needle-Free Drug Delivery Devices Market 2026, By The Business Research Company

Rotavirus Prophylaxis Global Market Report

https://www.thebusinessresearchcompany.com/report/rotavirus-prophylaxis-global-market-report

Appendicitis Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/appendicitis-treatment-global-market-report

Automotive Fascia Global Market Report

https://www.thebusinessresearchcompany.com/report/automotive-fascia-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795